Sabinsa Corporation manufactures and markets phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals for nutritional, pharmaceutical and food industries. Sabinsa has carved a niche for itself by its extensive research support for its customers and products, and the scientific credentials of its key technical staff. Founded in 1988 by Muhammed Majeed, Ph.D., Sabinsa is a company dedicated to the principles of tradition, innovation and research. Sabinsa's efforts have begun to earn the company vast recognition, in addition to growing sales.
The Japan Patent Office has awarded Sabinsa Corporation, headquartered in East Windsor, New Jersey, a patent for the company's water-soluble form of naturally available diterpenes derived from Coleus forskolii. The patent covers both the method for solubilizing diterpenes using randomly methylated β-cyclodextrin molecules and applications thereof in glaucoma. Sabinsa will market the product under the name OcuFors®.
OcuFors® is another breakthrough from Sabinsa: it is the first naturally derived pharmaceutical product that has been approved by the Drug Controller General of India. The company is seeking approval as a drug for glaucoma treatment in several other countries.
OcuFors® has been found to be superior drug for treatment of open-angle glaucoma and reducing the intraocular pressure better than Timolol, a non-selective beta blocker used in glaucoma treatment.
Dr. Muhammed Majeed, Chairman & Founder of the Sami & Sabinsa group of companies, said, "The patented water-soluble forskolin solution exemplifies the stringent research, development, safety and efficacy standards that constitute the Sabinsa group’s forte."
This patent represents the 73rd in Sabinsa Corporation's robust global patent portfolio.
About Sabinsa Corporation:
Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 20 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 full time scientists conducting ongoing research in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher and Halal. Visit www.sabinsa.com